A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non–Small Cell Lung Cancer is a research paper published in Clinical Lung Cancer (2021). On theSindex it has a DataRank of 1.2. It has been cited 42 times, with 35 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.564
From this paper's citation signal
Citation Network Contribution
0.592
From 26 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 35 citers.
National Institutes of Health
Grant: 5U54GM104942-04
West Virginia Clinical and Translational Science Institute: Improving Health through Partnerships and Transformative Research
National Institutes of Health
Grant: R01CA192064
National Institutes of Health
Grant: R01CA194013
National Institutes of Health
Grant: 2R01CA194013-06A1
In vivo monitoring of tumor microenvironment regulation for macrophages
National Institutes of Health
Grant: 5R01CA192064-03
Profiling chemical tumor microenvironment: application for diagnostics & therapy
FWCI
2.68
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models
Additional file 1 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models
Additional file 2 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models
Additional file 2 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models
Additional file 3 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models
Additional file 3 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models
Additional file 4 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models
Additional file 4 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models
Additional file 5 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models
Additional file 6 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models
Additional file 5 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models
Additional file 6 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models
Additional file 7 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models
Additional file 7 of Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models